Improving the health status of US working adults with type 2 diabetes mellitus: A review

Disease Management and Health Outcomes

Volumn 11, Issue 8, 2003, Pages 489-498

  Akinci, Fevzi ^a   Healey, Bernard J ^a   Coyne, Joseph S ^b,c  

^a KING'S COLLEGE   (United States)

^b WASHINGTON STATE UNIVERSITY   (United States)

^c PEKING UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ABSENCE; ADULT; BLINDNESS; COST OF ILLNESS; DISABILITY; HEALTH CARE COST; HEALTH EDUCATION; HEALTH PROGRAM; HEALTH STATUS; HUMAN; KIDNEY FAILURE; MANAGEMENT; NON INSULIN DEPENDENT DIABETES MELLITUS; QUALITY OF LIFE; REVIEW; UNITED STATES;

EID: 0041353425     PISSN: 11738790     EISSN: None     Source Type: Journal    
DOI: 10.2165/00115677-200311080-00002     Document Type: Review

References (45)

1. Centers for Disease Control and Prevention. Diabetes: disabling, deadly, and on the rise 2002. Atlanta (GA): National Center for Chronic Disease Prevention and Health Promotion, 2002
2. Boyle JP, Honeycutt AA, Narayan KM, et al. Projection of diabetes burden through 2050. Diabetes Care 2001; 24 (11): 1936-40
3. National Institutes of Health. Many obese youth have condition that precedes type 2 diabetes [news release]. 2003 Mar 13. Available from URL: http://www.nichd.nih.gov/mew/releases/obese.cfm
4. Sinha R, Fisch G, Teague B, et al. Prevalence of impaired glucose tolerance among children and adolescents with marked obesity. N Engl J Med 2002; 346: 802-10
5. Berg GD, Wadhwa S. Diabetes disease management in a community-based setting. Manag Care 2002; 11 (6): 42-50
6. DCCT Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993; 329: 977-86
7. UK Prospective Diabetes Study Group. UK Prospective Diabetes Study Group. Intensive blood-glucose control with sulfonylureas or insulin compared with conventional treatment and risk of complications in type 2 diabetes (UKPDS 33). Lancet 1998; 352: 837-53
8. Centers for Disease Control and Prevention. Making a difference: the business community takes on diabetes. Atlanta (GA): US Department of Health and Human Services Public Health Services, National Center for Chronic Disease Prevention and Health Promotion; 1999. Report No.: NPDP pub #33
9. Tuomilehto J, Lindstrom J, Ericksson JG, et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 2001; 344 (18): 1343-50
10. Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002; 346 (6): 393-403
11. Burton WN, Connerty RN. Worksite-based diabetes disease management program. Disease Management 2002; 5 (I): 1-8
12. Wing RR, Goldstein MG, Acton KJ, Behavioral science research in diabetes. Diabetes Care 2001; 24 (1): 117-23
13. Songer TJ, Ettaro L, Panel EoDP. Studies on the cost of diabetes: a report prepared for division of diabetes translation. Atlanta (GA): Centers for Disease Control and Prevention, 1998
14. American Diabetes Association. Economic costs of diabetes in the US. Diabetes Care 2003; 26 (3): 917-32
15. Peele P, Lave JR, Songer TJ. Diabetes in employer-sponsored health insurance. Diabetes Care 2002; 25 (11): 1964-8
16. D'Allegro J. $100B diabetes costs grab employers' attention. National Underwriter/Property & Casualty Risk & Benefits 1998; 102 (39): 41
17. Ramsey S, Summers K, Leong S, et al. Productivity and medical costs of diabetes in a large employer population. Diabetes Care 2002; 25: 23-9
18. Valdmanis V, Smith DW, Page MR. Productivity and economic burden associated with diabetes. Am J Public Health 2001; 91: 129-30
19. Mayfield JA, Deb P, Whitecotton L. Work disability and diabetes. Diabetes Care 1999; 22 (7): 1105-9
20. Ng YC, Jacobs P, Johnson JA. Productivity losses associated with diabetes in the US. Diabetes Care 2001; 24: 257-61
21. Yassin AS, Beckless GL, Messonnier ML. Disability and its economic impact among adults with diabetes. J Occup Environ Med 2002; 44 (2): 136-42
22. Employers' Managed Health Care Association. Taking on diabetes: diabetes in the workplace: how employers can implement change. Employers' Managed Health Care Association, 2002
23. American Diabetes Association. Economic consequences of diabetes mellitus in the United States in 1997. Diabetes Care 1998; 21: 296-309
24. Fleming B. The diabetes quality improvement project. Diabetes Care 2001; 24: 1815-20
25. American Diabetes Association. Standards of medical care for patients with diabetes mellitus. Diabetes Care 2002; 25 (1): 213-29
26. Rolka DB, Fagot-Campagna A, Narayan KM. Aspirin use among adults with diabetes. Diabetes Care 2001; 24 (2): 197-200
27. TRIAD Study Groups. The Translating Research into Action for Diabetes (TRIAD) study. Diabetes Care 2002; 25 (2): 386-9
28. Klonoff D. Schwartz D. An economic analysis of interventions for diabetes. Diabetes Care 2000; 23: 390-404
29. Testa MA, Simonson DC. Health economic benefits and quality of life during improved glycemic control in patients with type 2 diabetes mellitus: a randomized, controlled, double-blind trial. JAMA 1998; 280 (17): 1490-6
30. Burton W, Connerty C. Evaluation of a worksite-based patient education intervention targeted at employees with diabetes mellitus. J Occup Environ Med 1998; 40: 702-6
31. Trief PM, Aquilino C, Paradies K, et al. Impact of the work environment on glycemic control and adaptation to diabetes. Diabetes Care 1999; 22 (4): 569-74
32. Clark EA. A systematic approach to risk stratification and intervention within a managed care environment improves diabetes outcomes and patient satisfaction. Diabetes Care 2001; 25: 386-9
33. Gilmer T, O'Connor P, Manning W, et al. The cost to health plans of poor glycemic control. Diabetes Care 1997; 20: 1847-53
34. Menzin J, Langley-Hawthorne C, Friedman M, et al. Potential short-term economic benefits of improved glycemic control. Diabetes Care 2001; 24: 51-5
35. Sadur CN, Moline N, Costa M, et al. Diabetes management in a health maintenance organization: efficacy of care management using cluster visits. Diabetes Care 1999; 22 (12): 2011-7
36. Sidorov J, Shull R, Tomcavage J, et al. Does diabetes management save money and improve outcomes? A report of simultaneous short-term savings and quality improvement associated with a health maintenance organization-sponsored disease management program among patients fulfilling health employer data and information set criteria. Diabetes Care 2002; 25: 684-9
37. Selecky C. Integrating technology and interventions in the management of diabetes. Dis Manage Health Outcomes 2001; 9 Suppl. 1: 39-52
38. National Institute of Health. Diabetes statistics. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases, 1999
39. Javitt J. Aiello L. Cost-effectiveness of detecting and treating diabetic retinopathy. Ann Intern Med 1996; 119: 36-41
40. CDC Diabetes Cost-Effectiveness Group. Cost-effectiveness of intensive glycemic control, intensified hypertension control, and serum cholesterol level reduction for type 2 diabetes. JAMA 2002; 287: 2542-51
41. Harris M, Cowie CC, Stern MP, et al. Diabetes in America. 2nd ed. Washington, DC: Government Printing Office, 1995
42. Rodby R, Firth L, Lewis E. An economic analysis of captopril in the treatment of diabetes nephropathy. Diabetes Care 1996; 19: 1051-61
43. Elixhauser A, Weschler J, Kitzmiller JL. Cost-benefit analysis of preconception care for women with established diabetes mellitus. Dibetes Care 1993; 16: 1146-57
44. Healey BJ, Hromchak M, Akinci F, et al. Diabetes in the workplace. Proceedings of the Academy of Health Care Management. Las Vegas (NV): Allied Academics, 2002 Nov: 1-8
45. American Diabetes Association. Third-party reimbursement for diabetes care. self-management education, and supplies. Diabetes Care Suppl 2002; 25: S134-5